United States · 
Who invested in Gemstone Biotherapeutics?
Gemstone Biotherapeutics's investors include National Science Foundation and Gamma3.
2016201720182019
$2.5MSeed$250KVenture
United States · Venture startup
Who invested in Gemstone Biotherapeutics
Funding summaryUpdated 26 Oct 2026
$2.7Mraised across 2 rounds since 2015, from 2 sources
$2.5MSeed$250KVenture
- Latest round
- Venture, $250KAug 2019
- Biggest round
- $2.5MSeed · Jun 2015
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $2.5M Jun 2015
- Biggest round
- $2.5M Seed · Jun 2015
- Between rounds
- 4.2 years from the last two
The rounds
- Aug 2019
- Jun 2015
Founders and team
From the SEC filings it signed: 2 on the team.
- David OrosDirector, Promoteri
- George DavisExecutive Officer, Director, Promoteri
On the board, as filediGeoff MackayXin Huang
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Gemstone Biotherapeutics
How much has Gemstone Biotherapeutics raised?
Gemstone Biotherapeutics has raised $2.7M across 2 rounds since 2015.
When did Gemstone Biotherapeutics last raise?
Gemstone Biotherapeutics's most recent round was a Venture of $250K in Aug 2019.
What was Gemstone Biotherapeutics's biggest round?
Gemstone Biotherapeutics's largest round on record is $2.5M (Seed), in Jun 2015.
Who backed Gemstone Biotherapeutics first?
Gemstone Biotherapeutics's first round on record, in Jun 2015, was backed by Gamma3.
What stage is Gemstone Biotherapeutics at?
Gemstone Biotherapeutics's latest named round is a Venture, in Aug 2019.
Where is Gemstone Biotherapeutics based?
Gemstone Biotherapeutics is based in the United States.
Companies like Gemstone Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.